BTIM Corp. increased its stake in Danaher Co. (NYSE:DHR) by 14.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,345 shares of the company’s stock after buying an additional 1,075 shares during the period. BTIM Corp.’s holdings in Danaher were worth $775,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the company. Manning & Napier Advisors boosted its position in shares of Danaher by 9.4% in the fourth quarter. Manning & Napier Advisors now owns 1,234,292 shares of the company’s stock worth $114,640,000 after buying an additional 106,070 shares in the last quarter. Chevy Chase Trust Holdings boosted its position in shares of Danaher by 2.6% in the fourth quarter. Chevy Chase Trust Holdings now owns 875,335 shares of the company’s stock worth $81,300,000 after buying an additional 22,034 shares in the last quarter. PGGM Investments boosted its position in shares of Danaher by 0.4% in the fourth quarter. PGGM Investments now owns 309,140 shares of the company’s stock worth $28,713,000 after buying an additional 1,194 shares in the last quarter. Nisa Investment Advisors boosted its position in shares of Danaher by 6.2% in the fourth quarter. Nisa Investment Advisors now owns 183,232 shares of the company’s stock worth $17,019,000 after buying an additional 10,666 shares in the last quarter. Finally, Middleton & Company boosted its position in shares of Danaher by 1.2% in the fourth quarter. Middleton & Company now owns 156,574 shares of the company’s stock worth $14,542,000 after buying an additional 1,881 shares in the last quarter.

Danaher Co. (NYSE:DHR) opened at 86.65 on Friday. The firm’s 50-day moving average price is $89.53 and its 200-day moving average price is $90.26. The stock has a market cap of $59.38 billion and a price-to-earnings ratio of 18.55. Danaher Co. has a 12-month low of $81.25 and a 12-month high of $97.62.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 26th. The company reported $1.27 EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.27. The company earned $5.88 billion during the quarter, compared to the consensus estimate of $6.03 billion. The company’s revenue was up 12.6% compared to the same quarter last year. During the same period last year, the firm posted $1.04 earnings per share. On average, equities analysts predict that Danaher Co. will post $4.86 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Friday, January 29th. Shareholders of record on Monday, December 21st were issued a $0.135 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.03. This represents a $0.54 annualized dividend and a yield of 0.62%. The ex-dividend date of this dividend was Thursday, December 17th.

A number of equities analysts recently issued reports on the company. Goldman Sachs increased their target price on Danaher from $103.00 to $104.00 and gave the stock a “buy” rating in a report on Tuesday, November 24th. Sanford C. Bernstein raised their price objective on Danaher from $106.00 to $110.00 and gave the company an “outperform” rating in a research note on Monday, November 30th. Citigroup Inc. upgraded Danaher to a “top pick” rating in a research note on Thursday, November 26th. Zacks Investment Research cut Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, November 3rd. Finally, Jefferies Group raised their price objective on Danaher to $105.00 and gave the company a “buy” rating in a research note on Tuesday, November 10th. Eight investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. Danaher has an average rating of “Buy” and an average target price of $96.35.

In other news, CEO Thomas Patrick Joyce, Jr. sold 25,300 shares of the company’s stock in a transaction on Wednesday, January 27th. The stock was sold at an average price of $83.98, for a total transaction of $2,124,694.00. Following the transaction, the chief executive officer now directly owns 115,823 shares of the company’s stock, valued at $9,726,815.54. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP James A. Lico sold 55,840 shares of the company’s stock in a transaction on Tuesday, November 24th. The shares were sold at an average price of $96.40, for a total value of $5,382,976.00. Following the transaction, the executive vice president now directly owns 135,405 shares in the company, valued at $13,053,042. The disclosure for this sale can be found here.

Danaher Corporation (NYSE:DHR) designs, manufactures and markets professional, medical, industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. The Test & Measurement segment offers test, measurement and monitoring products. The Environmental segment products and services help protect the global water supply, facilitate environmental stewardship and enhance the safety of personal data. The Company’s diagnostics business offers analytical instruments, reagents, consumables, software and services. The Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The Company’s Industrial Technologies solutions help protect the world’s food supply, improve packaging design and quality, verify pharmaceutical dosages and authenticity and power innovative machines.

12 Month Chart for NYSE:DHR

Receive News & Ratings for Danaher Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Co. and related companies with MarketBeat.com's FREE daily email newsletter.